PI 3-kinase and MEK kinase inhibitors differentially affect IgE-dependent and IgE-independent basophil mediator release.
Gibbs
B F
BF
Department of Dermatology, Medical University of Lübeck, Germany.
Grabbe
J
J
D001491:Basophils / Q000502:physiology*; D015550:Cell Degranulation / Q000187:drug effects; D006801:Humans; D007073:Immunoglobulin E / Q000502:physiology; D020930:MAP Kinase Kinase Kinases / Q000037:antagonists & inhibitors / Q000502:physiology; D019869:Phosphatidylinositol 3-Kinases / Q000502:physiology; D000081082:Phosphoinositide-3 Kinase Inhibitors; D015398:Signal Transduction / Q000187:drug effects
D007073:Immunoglobulin E; D020930:MAP Kinase Kinase Kinases; D019869:Phosphatidylinositol 3-Kinases; D000081082:Phosphoinositide-3 Kinase Inhibitors